1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation. 2011; 123(4):e18– e209. Epub 2010/12/17. https://doi.org/10.1161/CIR.0b013e3182009701 PMID: 21160056.
2. Spencer FA, Meyer TE, Gore JM, Goldberg RJ. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocar- dial Infarction. Circulation. 2002; 105(22):2605–10. Epub 2002/06/05. https://doi.org/10.1161/01.cir. 0000017861.00991.2f PMID: 12045165.
3. Wu AH, Parsons L, Every NR, Bates ER, Second National Registry of Myocardial I. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol. 2002; 40 (8):1389–94. Epub 2002/10/24. https://doi.org/10.1016/s0735-1097(02)02173-3 PMID: 12392826.
4. Gonzalez A, Ravassa S, Beaumont J, Lopez B, Diez J. New targets to treat the structural remodeling of the myocardium. J Am Coll Cardiol. 2011; 58(18):1833–43. Epub 2011/10/25. https://doi.org/10.1016/j. jacc.2011.06.058 PMID: 22018293.
5. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990; 81(4):1161–72. Epub 1990/04/01. https://doi.org/10.1161/ 01.cir.81.4.1161 PMID: 2138525.
6. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002; 347(5):305–13. Epub 2002/08/02. https://doi.org/10.1056/ NEJMoa020245 PMID: 12151467.
7. Sun M, Tan Y, Rexiati M, Dong M, Guo W. Obesity is a common soil for premature cardiac aging and heart diseases—Role of autophagy. Biochim Biophys Acta Mol Basis Dis. 2019; 1865(7):1898–904. Epub 2019/05/22. https://doi.org/10.1016/j.bbadis.2018.09.004 PMID: 31109454.
8. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011; 11(2):85–97. Epub 2011/01/22. https://doi.org/10.1038/nri2921 PMID: 21252989; PubMed Central PMCID: PMC3518031.
9. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes. 2006; 55 (6):1537–45. https://doi.org/10.2337/db06-0263 PMID: 16731815.
10. Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, Gokce N, et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem. 2010; 285(9):6153–60. https://doi. org/10.1074/jbc.M109.088708 PMID: 20028977.
11. Packer M. Leptin-Aldosterone-Neprilysin Axis: Identification of Its Distinctive Role in the Pathogenesis of the Three Phenotypes of Heart Failure in People With Obesity. Circulation. 2018; 137(15):1614–31. Epub 2018/04/11. https://doi.org/10.1161/CIRCULATIONAHA.117.032474 PMID: 29632154.
12. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Obesity and risk of incident heart fail- ure in older men with and without pre-existing coronary heart disease: does leptin have a role? J Am Coll Cardiol. 2011; 58(18):1870–7. Epub 2011/10/25. https://doi.org/10.1016/j.jacc.2011.06.057 PMID: 22018297.
13. Alpert MA, Karthikeyan K, Abdullah O, Ghadban R. Obesity and Cardiac Remodeling in Adults: Mecha- nisms and Clinical Implications. Prog Cardiovasc Dis. 2018; 61(2):114–23. Epub 2018/07/11. https:// doi.org/10.1016/j.pcad.2018.07.012 PMID: 29990533.
14. Enomoto T, Ohashi K, Shibata R, Higuchi A, Maruyama S, Izumiya Y, et al. Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism. J Biol Chem. 2011; 286 (40):34552–8. Epub 2011/08/19. https://doi.org/10.1074/jbc.M111.277319 PMID: 21849507; PubMed Central PMCID: PMC3186379.
15. Wei Z, Peterson JM, Lei X, Cebotaru L, Wolfgang MJ, Baldeviano GC, et al. C1q/TNF-related Protein- 12 (CTRP12), a Novel Adipokine That Improves Insulin Sensitivity and Glycemic Control in Mouse Mod- els of Obesity and Diabetes. J Biol Chem. 2012; 287(13):10301–15. Epub 2012/01/26. https://doi.org/ 10.1074/jbc.M111.303651 PMID: 22275362.
16. Ogawa H, Ohashi K, Ito M, Shibata R, Kanemura N, Yuasa D, et al. Adipolin/CTRP12 protects against pathological vascular remodelling through suppression of smooth muscle cell growth and macrophage inflammatory response. Cardiovasc Res. 2020; 116(1):237–49. Epub 2019/03/16. https://doi.org/10. 1093/cvr/cvz074 PMID: 30874788.
17. Enomoto T, Shibata R, Ohashi K, Kambara T, Kataoka Y, Uemura Y, et al. Regulation of adipolin/ CTRP12 cleavage by obesity. Biochem Biophys Res Commun. 2012; 428(1):155–9. Epub 2012/10/17. https://doi.org/10.1016/j.bbrc.2012.10.031 PMID: 23068097.
18. Joki Y, Ohashi K, Yuasa D, Shibata R, Kataoka Y, Kambara T, et al. Neuron-derived neurotrophic factor ameliorates adverse cardiac remodeling after experimental myocardial infarction. Circ Heart Fail. 2015; 8(2):342–51. Epub 2015/02/07. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001647 PMID:25654972.
19. Joki Y, Ohashi K, Yuasa D, Shibata R, Ito M, Matsuo K, et al. FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism. Biochem Biophys Res Commun. 2015; 459(1):124–30. Epub 2015/02/26. https://doi.org/10.1016/j.bbrc.2015.02. 081 PMID: 25712519.
20. Yuasa D, Ohashi K, Shibata R, Mizutani N, Kataoka Y, Kambara T, et al. C1q/TNF-related protein-1 functions to protect against acute ischemic injury in the heart. FASEB J. 2016; 30(3):1065–75. Epub 2015/11/19. https://doi.org/10.1096/fj.15-279885 PMID: 26578687.
21. Otaka N, Shibata R, Ohashi K, Uemura Y, Kambara T, Enomoto T, et al. Myonectin Is an Exercise- Induced Myokine That Protects the Heart From Ischemia-Reperfusion Injury. Circ Res. 2018; 123 (12):1326–38. Epub 2018/12/20. https://doi.org/10.1161/CIRCRESAHA.118.313777 PMID: 30566056.
22. Kambara T, Ohashi K, Shibata R, Ogura Y, Maruyama S, Enomoto T, et al. CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism. J Biol Chem. 2012; 287(23):18965–73. Epub 2012/04/20. https://doi. org/10.1074/jbc.M112.357939 PMID: 22514273; PubMed Central PMCID: PMC3365930.
23. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Meth- ods. 2012; 9(7):671–5. Epub 2012/08/30. https://doi.org/10.1038/nmeth.2089 PMID: 22930834; PubMed Central PMCID: PMC5554542.
24. Frantz S, Bauersachs J, Ertl G. Post-infarct remodelling: contribution of wound healing and inflamma- tion. Cardiovascular research. 2009; 81(3):474–81. Epub 2008/11/04. https://doi.org/10.1093/cvr/ cvn292 PMID: 18977766; PubMed Central PMCID: PMC2639128.
25. Abbate A, Bussani R, Amin MS, Vetrovec GW, Baldi A. Acute myocardial infarction and heart failure: role of apoptosis. Int J Biochem Cell Biol. 2006; 38(11):1834–40. Epub 2006/06/20. https://doi.org/10. 1016/j.biocel.2006.04.010 PMID: 16781883.
26. Barron HV, Harr SD, Radford MJ, Wang Y, Krumholz HM. The association between white blood cell count and acute myocardial infarction mortality in patients > or = 65 years of age: findings from the coop- erative cardiovascular project. J Am Coll Cardiol. 2001; 38(6):1654–61. Epub 2001/11/13. https://doi. org/10.1016/s0735-1097(01)01613-8 PMID: 11704377.
27. Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and sup- pression of HuR. Circ Res. 2009; 104(2):e9–18. Epub 2008/12/20. https://doi.org/10.1161/ CIRCRESAHA.108.188243 PMID: 19096025; PubMed Central PMCID: PMC2774810.
28. Berry MF, Woo YJ, Pirolli TJ, Bish LT, Moise MA, Burdick JW, et al. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling. J Heart Lung Transplant. 2004; 23(9):1061–8. Epub 2004/09/30. https://doi.org/10.1016/j.healun.2004. 06.021 PMID: 15454172.
29. Ramani R, Mathier M, Wang P, Gibson G, Togel S, Dawson J, et al. Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling. Am J Physiol Heart Circ Physiol. 2004; 287(3):H1369–77. Epub 2004/08/20. https://doi.org/10.1152/ ajpheart.00641.2003 PMID: 15317681.
30. Chandrashekhar Y. Role of apoptosis in ventricular remodeling. Curr Heart Fail Rep. 2005; 2(1):18–22. Epub 2005/07/23. https://doi.org/10.1007/s11897-005-0003-5 PMID: 16036047.
31. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 2000; 101(6):660–7. Epub 2000/02/15. https://doi.org/10.1161/01.cir.101.6.660 PMID: 10673259; PubMed Central PMCID: PMC3627349.
32. Guha M, Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activa- tion of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem. 2002; 277(35):32124–32. Epub 2002/06/08. https://doi.org/10.1074/jbc.M203298200 PMID: 12052830.
33. Gu Y, Geng J, Xu Z, Chen Y, Zhang XW. Neutrophil Gelatinase-Associated Lipocalin2 Exaggerates Cardiomyocyte Hypoxia Injury by Inhibiting Integrin beta3 Signaling. Med Sci Monit. 2019; 25:5426–34. Epub 2019/07/23. https://doi.org/10.12659/MSM.915108 PMID: 31327865; PubMed Central PMCID: PMC6668495.
34. Wei Z, Lei X, Seldin MM, Wong GW. Endopeptidase cleavage generates a functionally distinct isoform of C1q/tumor necrosis factor-related protein-12 (CTRP12) with an altered oligomeric state and signaling specificity. J Biol Chem. 2012; 287(43):35804–14. Epub 2012/09/04. https://doi.org/10.1074/jbc.M112. 365965 PMID: 22942287; PubMed Central PMCID: PMC3476250.
35. Bell-Anderson KS, Funnell AP, Williams H, Mat Jusoh H, Scully T, Lim WF, et al. Loss of Kruppel-Like Factor 3 (KLF3/BKLF) Leads to Upregulation of the Insulin-Sensitizing Factor Adipolin (FAM132A/ CTRP12/C1qdc2). Diabetes. 2013; 62(8):2728–37. Epub 2013/05/02. https://doi.org/10.2337/db12- 1745 PMID: 23633521; PubMed Central PMCID: PMC3717849.
36. Enomoto T, Ohashi K, Shibata R, Kambara T, Uemura Y, Yuasa D, et al. Transcriptional Regulation of an Insulin-Sensitizing Adipokine Adipolin/CTRP12 in Adipocytes by Kruppel-Like Factor 15. PloS one. 2013; 8(12):e83183. Epub 2013/12/21. https://doi.org/10.1371/journal.pone.0083183 PMID: 24358263.
37. Aires V, Labbe J, Deckert V, Pais de Barros JP, Boidot R, Haumont M, et al. Healthy adiposity and extended lifespan in obese mice fed a diet supplemented with a polyphenol-rich plant extract. Sci Rep. 2019; 9(1):9134. Epub 2019/06/27. https://doi.org/10.1038/s41598-019-45600-6 PMID: 31235831; PubMed Central PMCID: PMC6591401.
38. Ahl S, Guenther M, Zhao S, James R, Marks J, Szabo A, et al. Adiponectin Levels Differentiate Metabol- ically Healthy vs Unhealthy Among Obese and Nonobese White Individuals. J Clin Endocrinol Metab. 2015; 100(11):4172–80. Epub 2015/09/25. https://doi.org/10.1210/jc.2015-2765 PMID: 26401592; PubMed Central PMCID: PMC4702448.
39. Fadaei R, Moradi N, Kazemi T, Chamani E, Azdaki N, Moezibady SA, et al. Decreased serum levels of CTRP12/adipolin in patients with coronary artery disease in relation to inflammatory cytokines and insu- lin resistance. Cytokine. 2019; 113:326–31. Epub 2018/10/20. https://doi.org/10.1016/j.cyto.2018.09. 019 PMID: 30337217.